These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 22028457

  • 1. Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization.
    Watanabe H, Nogami A, Ohkubo K, Kawata H, Hayashi Y, Ishikawa T, Makiyama T, Nagao S, Yagihara N, Takehara N, Kawamura Y, Sato A, Okamura K, Hosaka Y, Sato M, Fukae S, Chinushi M, Oda H, Okabe M, Kimura A, Maemura K, Watanabe I, Kamakura S, Horie M, Aizawa Y, Shimizu W, Makita N.
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):874-81. PubMed ID: 22028457
    [Abstract] [Full Text] [Related]

  • 2. Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A.
    Itoh H, Shimizu M, Mabuchi H, Imoto K.
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):378-83. PubMed ID: 15828879
    [Abstract] [Full Text] [Related]

  • 3. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
    Petitprez S, Jespersen T, Pruvot E, Keller DI, Corbaz C, Schläpfer J, Abriel H, Kucera JP.
    Cardiovasc Res; 2008 Jun 01; 78(3):494-504. PubMed ID: 18252757
    [Abstract] [Full Text] [Related]

  • 4. Abnormal restitution property of action potential duration and conduction delay in Brugada syndrome: both repolarization and depolarization abnormalities.
    Nishii N, Nagase S, Morita H, Kusano KF, Namba T, Miura D, Miyaji K, Hiramatsu S, Tada T, Murakami M, Watanabe A, Banba K, Sakai Y, Nakamura K, Oka T, Ohe T.
    Europace; 2010 Apr 01; 12(4):544-52. PubMed ID: 20083482
    [Abstract] [Full Text] [Related]

  • 5. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death.
    Rossenbacker T, Carroll SJ, Liu H, Kuipéri C, de Ravel TJ, Devriendt K, Carmeliet P, Kass RS, Heidbüchel H.
    Heart Rhythm; 2004 Nov 01; 1(5):610-5. PubMed ID: 15851228
    [Abstract] [Full Text] [Related]

  • 6. Expression and intracellular localization of an SCN5A double mutant R1232W/T1620M implicated in Brugada syndrome.
    Baroudi G, Acharfi S, Larouche C, Chahine M.
    Circ Res; 2002 Jan 11; 90(1):E11-6. PubMed ID: 11786529
    [Abstract] [Full Text] [Related]

  • 7. Functional suppression of sodium channels by beta(1)-subunits as a molecular mechanism of idiopathic ventricular fibrillation.
    Wan X, Wang Q, Kirsch GE.
    J Mol Cell Cardiol; 2000 Oct 11; 32(10):1873-84. PubMed ID: 11013131
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation.
    Probst V, Allouis M, Sacher F, Pattier S, Babuty D, Mabo P, Mansourati J, Victor J, Nguyen JM, Schott JJ, Boisseau P, Escande D, Le Marec H.
    J Cardiovasc Electrophysiol; 2006 Mar 11; 17(3):270-5. PubMed ID: 16643399
    [Abstract] [Full Text] [Related]

  • 11. Enhanced transmural dispersion of repolarization in patients with J wave syndromes.
    Karim Talib A, Sato N, Sakamoto N, Tanabe Y, Takeuchi T, Saijo Y, Kawamura Y, Hasebe N.
    J Cardiovasc Electrophysiol; 2012 Oct 11; 23(10):1109-14. PubMed ID: 22612896
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Facilitatory and inhibitory effects of SCN5A mutations on atrial fibrillation in Brugada syndrome.
    Amin AS, Boink GJ, Atrafi F, Spanjaart AM, Asghari-Roodsari A, Molenaar RJ, Ruijter JM, Wilde AA, Tan HL.
    Europace; 2011 Jul 11; 13(7):968-75. PubMed ID: 21273195
    [Abstract] [Full Text] [Related]

  • 14. Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy.
    Laurent G, Saal S, Amarouch MY, Béziau DM, Marsman RF, Faivre L, Barc J, Dina C, Bertaux G, Barthez O, Thauvin-Robinet C, Charron P, Fressart V, Maltret A, Villain E, Baron E, Mérot J, Turpault R, Coudière Y, Charpentier F, Schott JJ, Loussouarn G, Wilde AA, Wolf JE, Baró I, Kyndt F, Probst V.
    J Am Coll Cardiol; 2012 Jul 10; 60(2):144-56. PubMed ID: 22766342
    [Abstract] [Full Text] [Related]

  • 15. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G, Corrado D, Delise P, Fedele F, Gaita F, Gentile F, Giustetto C, Michelucci A, Padeletti L, Priori S.
    G Ital Cardiol (Rome); 2010 Nov 10; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugs.
    Itoh H, Shimizu M, Takata S, Mabuchi H, Imoto K.
    J Cardiovasc Electrophysiol; 2005 May 10; 16(5):486-93. PubMed ID: 15877619
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.